- Home
- ICCC vs XBP Comparison
ICCC vs XBP Comparison
Compare ICCC & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- XBP
- Stock Information
- Founded
- ICCC 1982
- XBP 2020
- Country
- ICCC United States
- XBP United States
- Employees
- ICCC N/A
- XBP N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- XBP Business Services
- Sector
- ICCC Health Care
- XBP Consumer Discretionary
- Exchange
- ICCC Nasdaq
- XBP Nasdaq
- Market Cap
- ICCC 60.1M
- XBP 71.0M
- IPO Year
- ICCC 1987
- XBP N/A
- Fundamental
- Price
- ICCC $5.92
- XBP $1.00
- Analyst Decision
- ICCC
- XBP
- Analyst Count
- ICCC 0
- XBP 0
- Target Price
- ICCC N/A
- XBP N/A
- AVG Volume (30 Days)
- ICCC 7.7K
- XBP 509.9K
- Earning Date
- ICCC 11-12-2025
- XBP 11-11-2025
- Dividend Yield
- ICCC N/A
- XBP N/A
- EPS Growth
- ICCC N/A
- XBP N/A
- EPS
- ICCC 0.20
- XBP N/A
- Revenue
- ICCC $28,274,756.00
- XBP $148,332,000.00
- Revenue This Year
- ICCC N/A
- XBP N/A
- Revenue Next Year
- ICCC N/A
- XBP N/A
- P/E Ratio
- ICCC $30.55
- XBP N/A
- Revenue Growth
- ICCC 21.75
- XBP 0.23
- 52 Week Low
- ICCC $3.34
- XBP $0.42
- 52 Week High
- ICCC $7.60
- XBP $2.56
- Technical
- Relative Strength Index (RSI)
- ICCC 41.72
- XBP 69.34
- Support Level
- ICCC $6.29
- XBP $0.65
- Resistance Level
- ICCC $6.42
- XBP $0.90
- Average True Range (ATR)
- ICCC 0.24
- XBP 0.09
- MACD
- ICCC -0.02
- XBP 0.05
- Stochastic Oscillator
- ICCC 1.82
- XBP 97.70
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About XBP XBP Europe Holdings Inc.
XBP Global Holdings Inc is a multinational leader in business process automation, serving over 2,500 clients-including more than 30 Fortune 100 companies. Its proprietary software and deep domain expertise position it as a trusted technology and services partner. With cloud-based solutions and a global footprint, XBP Global delivers measurable value, improves advances digital transformation, improves market-wide liquidity by expediting payments, and promotes sustainable business practices.